Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy

The aim of this study was to establish the suitability of the North Star Ambulatory Assessment for use in young boys with Duchenne muscular dystrophy. We studied 147 typically developing and 144 boys affected by Duchenne muscular dystrophy between the ages of 3 and 5 years. More than 85% of the typically developing boys by the age of 4 years had full scores on all the items with total scores ≥33/34. Before the age of 4 years more than 15% of the typically developing boys did not achieve full scores on all the items. Some items, such as standing on one leg, showed significant improvement with age. In contrast, other activities were rarely achieved even in the older boys. Even if there was a progressive increase in scores with age, both total and individual item scores in Duchenne were still far from those obtained in the typically developing children of the same age. Our findings suggest that the North Star Ambulatory Assessment can be reliably used at least from the age of 4 years. Longitudinal natural history data studies are needed to assess possible changes over time and the possible effect of early steroids.

[1]  E. Bertini,et al.  Early neurodevelopmental assessment in Duchenne muscular dystrophy , 2013, Neuromuscular Disorders.

[2]  K. Bushby,et al.  Molecular treatments in Duchenne muscular dystrophy. , 2010, Current opinion in pharmacology.

[3]  Kevin M Flanigan,et al.  The Muscular Dystrophies , 1999, Seminars in Neurology.

[4]  M. Main,et al.  Reliability of the North Star Ambulatory Assessment in a multicentric setting , 2009, Neuromuscular Disorders.

[5]  J. Miller,et al.  Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network , 2013, Neuromuscular Disorders.

[6]  Jay J. Han,et al.  The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used , 2013, Muscle & nerve.

[7]  Marika Pane,et al.  North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy , 2010, Neuromuscular Disorders.

[8]  Francesco Muntoni,et al.  Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. , 2012, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[9]  S. Peltz,et al.  THE 6-MINUTE WALK TEST AND OTHER ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: LONGITUDINAL NATURAL HISTORY OBSERVATIONS OVER 48 WEEKS FROM A MULTICENTER STUDY , 2013, Muscle & nerve.

[10]  S. Gasperini,et al.  Functional changes in Duchenne muscular dystrophy , 2011, Neurology.

[11]  S. Peltz,et al.  THE 6-MINUTE WALK TEST AND OTHER CLINICAL ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: RELIABILITY, CONCURRENT VALIDITY, AND MINIMAL CLINICALLY IMPORTANT DIFFERENCES FROM A MULTICENTER STUDY , 2013, Muscle & nerve.

[12]  K. Bushby,et al.  Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. , 2011, Clinical investigation.

[13]  K. Davies,et al.  Therapeutic approaches to muscular dystrophy. , 2011, Human molecular genetics.

[14]  Eugenio Mercuri,et al.  Muscular dystrophies , 2013, The Lancet.